Castle Biosciences (CSTL) Acquisitions (2022)

Castle Biosciences (CSTL) posted Acquisitions of $305000.0 for Q3 2022.

Castle Biosciences (CSTL) Acquisitions (2022) Analysis & Trends

Castle Biosciences has reported Acquisitions for 1 years, with the latest figure at $305000.0 in Q3 2022.

  • Quarterly Acquisitions changed N/A year-over-year to $305000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2023 was $305000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $27.0 million, changed N/A from the prior year.
  • Acquisitions was little changed at $305000.0 in Q3 2022 per CSTL's latest filing.
  • Over five years, Acquisitions peaked at $305000.0 in Q3 2022 and troughed at $305000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn 163.00 Mn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn -
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Castle Biosciences 923.37 Mn 656.55 Mn 79.85 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 305,000.00